BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 16334163)

  • 1. Expression of p53, cyclin D1 and Ki-67 in pre-malignant and malignant oral lesions: association with clinicopathological parameters.
    Raju B; Mehrotra R; Oijordsbakken G; Al-Sharabi AK; Vasstrand EN; Ibrahim SO
    Anticancer Res; 2005; 25(6C):4699-706. PubMed ID: 16334163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of p53 and Ki-67 genes in epithelial dysplasia from old oral mucosa and clinical significance].
    Zhao J; Guo B; Ma SC; Zhou XD
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Sep; 36(5):689-91. PubMed ID: 16235539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expressions of FHIT and cyclin D1/CDK4 in oral cancer and oral precancerous lesions].
    Yin C; Shen LJ; Xie SM; Ruan P; Yao X
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jul; 25(7):812-4. PubMed ID: 16027075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ
    J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin D1 expression and its possible regulation in chewing tobacco mediated oral squamous cell carcinoma progression.
    Mishra R; Das BR
    Arch Oral Biol; 2009 Oct; 54(10):917-23. PubMed ID: 19679297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of cyclin D1 and Ki-67 in squamous cell carcinoma of the penis.
    Papadopoulos O; Betsi E; Tsakistou G; Frangoulis M; Kouvatseas G; Anagnostakis D; Kouvidou Ch
    Anticancer Res; 2007; 27(4B):2167-74. PubMed ID: 17695500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical expression of cell-cycle proteins in gastric precancerous lesions.
    Anagnostopoulos GK; Stefanou D; Arkoumani E; Karagiannis J; Paraskeva K; Chalkley L; Habilomati E; Tsianos E; Agnantis NJ
    J Gastroenterol Hepatol; 2008 Apr; 23(4):626-31. PubMed ID: 18397488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor risk assessment by means of immunocytochemical detection of early pre-malignant changes in buccal smears.
    Bloching MM; Soulsby H; Naumann A; Aust W; Merkel D; Braun T; Naim R
    Oncol Rep; 2008 Jun; 19(6):1373-9. PubMed ID: 18497939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of p53 and Ki-67 protein expression in epithelial dysplasia from the floor of the mouth.
    Kushner J; Bradley G; Jordan RC
    J Pathol; 1997 Dec; 183(4):418-23. PubMed ID: 9496258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The overexpression of p53 and proliferative activity in precancerous and cancerous lesions of oral squamous epithelium.
    Ichikawa M; Ishii K; Nakajima T; Mogi K
    J Exp Clin Cancer Res; 1997 Jun; 16(2):141-6. PubMed ID: 9261738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher expressions of p53 and proliferating cell nuclear antigen (PCNA) in atrophic oral lichen planus and patients with areca quid chewing.
    Lee JJ; Kuo MY; Cheng SJ; Chiang CP; Jeng JH; Chang HH; Kuo YS; Lan WH; Kok SH
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Apr; 99(4):471-8. PubMed ID: 15772596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of Ki67, p53 and RARbeta expression in normal, premalignant and malignant human oral epithelial cells by chemopreventive agents.
    D'Ambrosio SM; Gibson-D'Ambrosio RE; Wani G; Casto B; Milo GE; Kelloff GJ; Steele VE
    Anticancer Res; 2001; 21(5):3229-35. PubMed ID: 11848477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type IV collagen and CD44v6 expression in benign, malignant primary and metastatic ovarian tumors: correlation with Ki-67 and p53 immunoreactivity.
    Bar JK; Grelewski P; Popiela A; Noga L; Rabczyñski J
    Gynecol Oncol; 2004 Oct; 95(1):23-31. PubMed ID: 15385106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of cyclin D1 in Chinese patients with breast carcinoma and its correlation with Ki-67, pRb, and p53.
    Guo LL; Gao P; Wu YG; Jian WC; Hao CY; Li H; Lin XY
    Arch Med Res; 2007 Nov; 38(8):846-52. PubMed ID: 17923265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Premalignant lesions in the contralateral ovary of women with unilateral ovarian carcinoma.
    Kaur TB; Shen T; Gaughan J; Thompson J; Houck KL; Richardson M; Hernandez E
    Gynecol Oncol; 2004 Apr; 93(1):69-77. PubMed ID: 15047216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of Ki-67 and cyclin D1 in invasive extramammary Paget's disease.
    Aoyagi S; Akiyama M; Shimizu H
    J Dermatol Sci; 2008 Jun; 50(3):177-84. PubMed ID: 18248961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ki-67, cyclin D1, p53 and bcl-2 expression in advanced head and neck cancer.
    Nagy B; Tiszlavicz L; Eller J; Molnar J; Thurzo L
    In Vivo; 2003; 17(1):93-6. PubMed ID: 12655798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Ki-67, cyclin D1 and apoptosis markers correlated with survival in prostate cancer patients treated by radical prostatectomy.
    Aaltomaa S; Kärjä V; Lipponen P; Isotalo T; Kankkunen JP; Talja M; Mokka R
    Anticancer Res; 2006; 26(6C):4873-8. PubMed ID: 17214354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of ERK1/2 and cyclin D1 expression in oral tongue squamous cell carcinomas: relationship between clinicopathological appearances and cell proliferation.
    Wang L; Liu T; Nishioka M; Aguirre RL; Win SS; Okada N
    Oral Oncol; 2006 Jul; 42(6):625-31. PubMed ID: 16483832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.